C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof

Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
11/2009
11/11/2009	CN100558894C Synthetic gene encoding human epidermal growth factor 2/NEU antigen and uses thereof
11/10/2009	US7615686 Pesticidal Vip3 toxins toxin from Bacillus thuringiensis highly active against a wide range of lepidopteran insect pests is disclosed. The DNA encoding the pesticidal toxin; used to transform various prokaryotic and eukaryotic organisms to express the pesticidal toxin;crops; genetic engineering
11/10/2009	CA2251027C Defective viral vaccine particles obtained in vivo or ex vivo
11/05/2009	WO2009134717A1 Chimeric west nile/dengue viruses
11/05/2009	WO2009133054A1 Novel avian astrovirus
11/05/2009	WO2009132484A1 Lytic proteins of vero cell, preparation method thereof and detection kit for vero hcp comprising the same
11/05/2009	WO2009054996A8 Systems and methods for viral therapy
11/05/2009	WO2009041831A9 PHAGE ϕMRU POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF
11/05/2009	US20090275138 PRODUCTION OF rAAV IN VERO CELLS USING PARTICULAR ADENOVIRUS HELPERS
11/05/2009	US20090275107 Scalable Production Method for AAV
11/05/2009	US20090274792 Novel bacterial phytases and method for producing same
11/05/2009	US20090274728 Mutant Viruses
11/05/2009	US20090274727 Recombinant RSV Virus Expression Systems And Vaccines
11/05/2009	US20090274724 Novel recombinant and mutant adenoviruses
11/05/2009	US20090274723 Modified vaccinia ankara virus vaccine
11/05/2009	US20090274670 Dph2 gene deletion mutant and uses thereof
11/04/2009	EP2113569A1 Recombinant adenoviral vector and methods of use
11/03/2009	US7611884 Toxoplasma gondii nucleic acid molecules
11/03/2009	US7611831 Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
11/03/2009	US7611719 Enterovirus, vaccines, medicaments and diagnostic kits
11/03/2009	US7611712 Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide
11/03/2009	CA2418442C Novel helper functions for recombinant vector production
11/03/2009	CA2289611C Method for the production of non-group c adenoviral vectors
11/03/2009	CA2188293C Herpesviruses transformed to express gd in vitro
10/2009
10/29/2009	WO2009132195A1 Immortal avian cell line and methods of use
10/29/2009	WO2009131606A2 Viral inactivation using crosslinkers and detergents
10/29/2009	WO2009131203A1 Nucleic acid containing chimeric gene derived from hepatitis type-c virus
10/29/2009	WO2009130516A1 Alive tool to transfer immunomodulation applying target-transfection mediated by the genes referred in the text
10/29/2009	WO2009130261A1 Vaccine compositions for the treatment of dengue fever and uses thereof
10/29/2009	US20090270318 High-affinity antagonists of elr-cxc chemokines
10/29/2009	US20090269850 containing a reduced amount of receptor-binding protein compared with the wild type; modified HVJ containing a reduced amount of HN protein
10/29/2009	US20090269619 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications
10/29/2009	US20090269365 Immunogenic vaccinia peptides and methods of using same
10/29/2009	US20090269342 Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
10/29/2009	US20090269249 Allergen inactivating method, allergen inactivating filter, air treating apparatus, virus inactivating agent, virus inactivating method, virus inactivating filter, air conditioning unit and air conditioner
10/29/2009	CA2722043A1 Nucleic acid comprising chimeric gene derived from hepatitis c virus
10/29/2009	CA2721657A1 Vaccine compositions for the treatment of dengue fever and uses thereof
10/28/2009	EP2112225A1 Recombinant pox virus for immunization against tumor-associated antigens
10/28/2009	EP2112220A2 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
10/28/2009	EP1570051B1 Genetic constructs and compositions comprising rre and cte and uses thereof
10/28/2009	EP1453956B1 Method for large scale production of virus antigen
10/28/2009	EP1071758B1 Porcine adenovirus vector
10/28/2009	CN101568647A Secretion of antibodies without signal peptides from bacteria
10/28/2009	CN101568639A Medium supplement for virus production
10/28/2009	CN101565692A Construction and application of multiple target-point anti-cancer adenoviruses
10/28/2009	CN101565691A Method of separating and purifying single virus
10/27/2009	US7608449 Methods and compositions related to high-titer pseudotyped retroviruses
10/27/2009	US7608422 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes
10/27/2009	US7608410 Method of improving T cell receptors
10/27/2009	US7608273 glycoprotein cationic polypeptide as HIV vaccines; nontoxic
10/27/2009	US7608255 Replication-competent anti-cancer vectors
10/27/2009	CA2329283C Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby
10/22/2009	WO2009127537A1 Post release modification of viral envelopes
10/22/2009	WO2009127154A1 A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs
10/22/2009	WO2009127081A1 A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs
10/22/2009	WO2009093251A3 Reovirus vaccine based on sigma c protein sequence
10/22/2009	WO2009045581A3 Bacteriophage with enhanced lytic activity
10/22/2009	US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009	US20090263895 Cell line for producing a non-retroviral vector
10/22/2009	US20090263883 Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
10/22/2009	US20090263424 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
10/22/2009	DE102005027956B4 Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen Poxvirusstämme highly attenuated, processes for their preparation and their use as paramunity inducers or for the preparation of vector vaccines
10/21/2009	EP2110382A1 Infectious cDNA of an improved vaccine strain of measles virus, use for immunogenic compositions
10/21/2009	EP1496118B1 Method of measuring human cyp3a inducibility
10/21/2009	CN101563463A Intergenic sites between conserved genes in the genome of modified vaccinia ankara (MVA) vaccinia virus
10/21/2009	CN101563361A Influenza viruses able to infect canids, uses thereof
10/21/2009	CN101560520A Japanese encephalitis/dengue chimeric virus and application thereof
10/21/2009	CN101560503A Influenza A virus Vero cell adapted strain and application thereof
10/21/2009	CN101560502A Herpes virus strains for gene therapy
10/21/2009	CN101560501A Recombinant adenovirus capable of selectively expressing FADD, construction method and application thereof
10/21/2009	CN101559224A Poliomyelitis vaccine
10/20/2009	US7604977 Inhibiting HIV replication in an HIV-infected cell by contacting the cell with a compound which down-regulates expression of an isopeptidase T-encoding gene, thereby inhibiting HIV replication in the cell
10/20/2009	US7604935 Soluble rubella E1 envelope protein variants
10/20/2009	CA2341354C Dengue viruses that are replication defective in mosquitos for use as vaccines
10/20/2009	CA2227467C Helper virus-free herpesvirus vector packaging system
10/15/2009	US20090258935 Hybrid adeno-retroviral vector for the transfection of cells
10/15/2009	US20090258396 Crustaceans as production systems for therapeutic proteins
10/15/2009	US20090258341 Compositions and Methods for Detecting Bacteria
10/15/2009	US20090258036 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3' -utr of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
10/15/2009	US20090257981 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
10/14/2009	EP1432737B1 Human mini-antibody cytotoxic for tumor cells which express the erbb2 receptor
10/14/2009	EP1372710B1 Mva expressing modified hiv envelope, gag, and pol genes
10/14/2009	EP1303302B1 Use of strains of the parapox ovis virus against organ fibrosis
10/14/2009	EP1232257B1 Modular transport systems for molecular substances and production and use thereof
10/14/2009	CN101558169A Treatment of pigs with PCV2 antigen
10/14/2009	CN101555630A Phage random peptide library of mycobacterium tuberculosis
10/14/2009	CN101555469A High-efficiency recombined adenovirus containing ndrg2 gene and pharmic purpose thereof
10/14/2009	CN101555468A Viral variants with altered susceptibility to nucleoside analogs and uses thereof
10/14/2009	CN100549164C Recombinant virus comprising tumor therapeutic full-antibody gene with human constant region and its use
10/13/2009	US7601825 Administering to cancer cells a vector that encodes a single chain monoclonal antibody that immunospecifically binds to an 121P1F1-related protein
10/13/2009	US7601812 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
10/13/2009	US7601356 Methods and compositions for increasing replication capacity of an influenza virus
10/13/2009	US7601343 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides
10/08/2009	WO2009123348A1 Method for concentration of virus
10/08/2009	WO2009076668A3 Bacteriophage preparations and method of use thereof
10/08/2009	US20090253897 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
10/08/2009	US20090253208 Genetic engineered herpes virus genomes; vaccine; gene transfer into T lymphoid cells comprising infecting a T lymphoid cell with a recombinant herpesvirus
10/08/2009	US20090252761 Papilloma virus vaccine
10/08/2009	US20090252748 Sp35 Antibodies and Uses Thereof
10/08/2009	CA2722957A1 Enrichment method of virus

1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 267